Live from the NIH registry
Studies recruiting near Brownsville right now
Top 25 of 63 recruiting studies, sorted by proximity — each links to its official registry page
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Brownsville, Texas (7.1 mi)
· Sponsor: Akero Therapeutics, Inc
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Obesity
Phase 3
Interventional 1,200 participants sought
Kailera Clinical Site — Brownsville, Texas (7.1 mi)
· Sponsor: Kailera
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
South Texas Research Institute - Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Boehringer Ingelheim
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Melanoma
Phase 3
Interventional 560 participants sought
Texas Oncology - Harlingen, Medical Arts Pavillion — Harlingen, Texas (19.9 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 600 participants sought
Cano Medical Center — Harlingen, Texas (19.9 mi)
· Sponsor: Hoffmann-La Roche
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Cervical Cancer
Phase 4
Interventional 100 participants sought
Texas Oncology - Central South — Harlingen, Texas (19.9 mi)
· Sponsor: Pfizer
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Crohn's Disease
Phase 3
Interventional 980 participants sought
Valley Institute of Research: 8400004 — Harlingen, Texas (19.9 mi)
· Sponsor: Sanofi
Prospective Study to Assess a Diagnostic Aid for Cancer
Cancer
N/A
Observational 1,650 participants sought
Texas Digestive — Harlingen, Texas (19.9 mi)
· Sponsor: Harbinger Health
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Brownsville, Texas (7.1 mi)
· Sponsor: 89bio, Inc.
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Obesity, Overweight
Phase 3
Interventional 1,560 participants sought
AURORA-2 Clinical Site — Brownsville, Texas (7.1 mi)
· Sponsor: Ascletis Pharma (China) Co., Limited
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Chronic Obstructive Pulmonary Disease
Phase 3
Interventional 942 participants sought
Valley Institute of Research- Site Number : 8400118 — Harlingen, Texas (19.9 mi)
· Sponsor: Sanofi
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
COPD
Phase 2
Interventional 171 participants sought
Proactive RGV — Brownsville, Texas (7.1 mi)
· Sponsor: Uniquity One (UNI)
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Heart Failure
Phase 2
Interventional 620 participants sought
Headlands Horizons, LLC dba Headlands Research-Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Pfizer
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Type 2 Diabetes
Phase 3
Interventional 600 participants sought
South Texas Research Institute - Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Boehringer Ingelheim
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
Texas Oncology- Central South — Harlingen, Texas (19.9 mi)
· Sponsor: Pfizer
Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts
Cerebral Vasospasm, Aneurysmal Subarachnoid Hemorrhage (aSAH)
N/A
Observational 200 participants sought
Valley Baptist Medical Center- Harlingen — Harlingen, Texas (19.9 mi)
· Sponsor: Vesalio
Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions.
Sciatica Acute, Lumbar Spinal Stenosis
Phase 4
Interventional 50 participants sought
Integrative Rheumatology of South Texas — Harlingen, Texas (19.9 mi)
· Sponsor: Primus Pharmaceuticals
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
Influenza, Human
Phase 3
Interventional 54,000 participants sought
GSK Investigational Site — Brownsville, Texas (7.1 mi)
· Sponsor: GlaxoSmithKline
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Brownsville, Texas (7.1 mi)
· Sponsor: 89bio, Inc.
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Breast Cancer, Metastatic Breast Cancer
Phase 3
Interventional 404 participants sought
Texas Oncology - Harlingen — Harlingen, Texas (19.9 mi)
· Sponsor: BriaCell Therapeutics Corporation
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Brownsville, Texas (7.1 mi)
· Sponsor: Akero Therapeutics, Inc
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
N/A
Observational 8,000 participants sought
Amc Cavazos - Pa — Cavazos, Texas (9.4 mi)
· Sponsor: Stryker Instruments
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Obesity With Diabetes, Overweight With Diabetes
Phase 3
Interventional 1,156 participants sought
Kailera Clinical Site — Brownsville, Texas (7.1 mi)
· Sponsor: Kailera
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis
Phase 3
Interventional 350 participants sought
Cano Medical Center — Harlingen, Texas (19.9 mi)
· Sponsor: Hoffmann-La Roche
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Phase 3
Interventional 1,410 participants sought
Texas Oncology - Central/South Texas — Harlingen, Texas (19.9 mi)
· Sponsor: Pfizer